Construction of a plasmid-free L-leucine overproducing Escherichia coli strain through reprogramming of the metabolic flux

Biotechnol Biofuels Bioprod. 2023 Sep 29;16(1):145. doi: 10.1186/s13068-023-02397-x.

Abstract

Background: L-Leucine is a high-value amino acid with promising applications in the medicine and feed industries. However, the complex metabolic network and intracellular redox imbalance in fermentative microbes limit their efficient biosynthesis of L-leucine.

Results: In this study, we applied rational metabolic engineering and a dynamic regulation strategy to construct a plasmid-free, non-auxotrophic Escherichia coli strain that overproduces L-leucine. First, the L-leucine biosynthesis pathway was strengthened through multi-step rational metabolic engineering. Then, a cooperative cofactor utilization strategy was designed to ensure redox balance for L-leucine production. Finally, to further improve the L-leucine yield, a toggle switch for dynamically controlling sucAB expression was applied to accurately regulate the tricarboxylic acid cycle and the carbon flux toward L-leucine biosynthesis. Strain LEU27 produced up to 55 g/L of L-leucine, with a yield of 0.23 g/g glucose.

Conclusions: The combination of strategies can be applied to the development of microbial platforms that produce L-leucine and its derivatives.

Keywords: Dynamic regulation; Escherichia coli; L-Leucine; Metabolic engineering; Redox cofactors.